Publications
Filters: First Letter Of Last Name is Z [Clear All Filters]
“Efficacy of artesunate-amodiaquine for treating uncomplicated falciparum malaria in sub-Saharan Africa: a multi-centre analysis”, Malar J, vol. 8, p. 203, 2009.
, “Safety and efficacy of dihydroartemisinin-piperaquine in falciparum malaria: a prospective multi-centre individual patient data analysis”, PLoS ONE, vol. 4, no. 7, p. e6358, 2009.
, “Efficacy of artesunate-amodiaquine (ASAQ) for the treatment of uncomplicated falciparum malaria in sub-Saharan Africa: An individual patient data meta analysis (IPDM) in 3,455 patients”, in 56th Meeting of the American Society of Tropical Medicine and Hygiene, Philadelphia, USA, 2007, vol. 77, p. 287.
, “Efficacy and day 7 plasma piperaquine concentrations in African children treated for uncomplicated malaria with dihydroartemisinin-piperaquine”, PLoS One, vol. 9, no. 8, p. e103200, 2014.
, “Randomized Noninferiority Trial of Dihydroartemisinin-Piperaquine Compared with Sulfadoxine-Pyrimethamine plus Amodiaquine for Seasonal Malaria Chemoprevention in Burkina Faso”, Antimicrobial Agents and Chemotherapy, vol. 59, no. 8, pp. 4387-4396, 2015.
, “New insights into the Plasmodium vivax transcriptome using RNA-Seq”, Sci Rep, vol. 6, p. 20498, 2016.
, “The origins of malaria artemisinin resistance defined by a genetic and transcriptomic background”, Nat Commun, vol. 9, no. 1, p. 5158, 2018.
, “Rheopathologic Consequence of Plasmodium vivax Rosette Formation”, PLoS Negl Trop Dis, vol. 10, no. 8, p. e0004912, 2016.
, “Therapeutic disruption of Plasmodium vivax infected red cell deformability”, Malaria Journal, vol. 13, no. Suppl 1, p. O25, 2014.
, “A Basis for Rapid Clearance of Circulating Ring-Stage Malaria Parasites by the Spiroindolone KAE609”, J Infect Dis, vol. 213, no. 1, pp. 100-4, 2016.
,